{"id":"W2121174591","doi":"10.1016/j.jaci.2009.08.047","title":"Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma","year":2009,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada); Université Laval; University of British Columbia; University of Saskatchewan; McMaster University","funders":"Canadian Institutes of Health Research; Canadian Thoracic Society; Université Laval; GlaxoSmithKline; Genentech; AstraZeneca; Alexion Pharmaceuticals; Pfizer","keywords":"Methacholine; Medicine; Asthma; Placebo; Anesthesia; Crossover study; Tolerability; Bronchodilator; Inhaler; Provocation test; Agonist; Inhalation; Pharmacology; Internal medicine; Respiratory disease; Adverse effect; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003649105,0.0004370875,0.001428112,0.0002678467,0.000340034,0.0003251136,0.0002296113,0.0004683076,0.001025329],"category_scores_gemma":[0.0007584287,0.0002247562,0.0006731222,0.0002001312,0.0001844285,0.0002954522,0.000194776,0.0007162236,0.0001700097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002853846,"about_ca_system_score_gemma":0.0002770075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001903683,"about_ca_topic_score_gemma":0.002396784,"domain_scores_codex":[0.9998093,0.00005586044,0.00002086347,0.00002406552,0.00003927485,0.00005059823],"domain_scores_gemma":[0.999588,0.00008434504,0.00008019544,0.00001863113,0.00003426965,0.0001945757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08486191,0.001731712,0.7893484,0.000444278,0.001256659,0.003115621,0.0003848626,0.0004125379,0.05701696,0.00005905212,0.000872638,0.06049532],"study_design_scores_gemma":[0.0006824597,0.008156508,0.9887342,0.00001262985,0.0003255774,0.0007181695,0.00007453383,0.0002351021,0.000739101,0.00001661125,0.0002937568,0.00001144772],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997072,0.002327881,0.00004854749,0.0001122726,0.00003202563,0.0000168613,0.00007209348,0.00001024061,0.0003081292],"genre_scores_gemma":[0.9989892,0.0004328305,0.00004744792,0.00007803868,0.00004342679,0.00001131609,0.0001361747,0.000001442282,0.0002600697],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001903683,"threshold_uncertainty_score":0.003785253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01385218754481961,"score_gpt":0.2968453020948782,"score_spread":0.2829931145500586,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}